Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
International Urology and Nephrology|July 22, 2018
Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?Andreja Figurek, Goce Spasovski
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 4, 2017
FGF23 Level and Intima-Media Thickness Are Elevated From Early Stages of Chronic Kidney DiseaseAndreja Figurek, Goce Spasovski, Snjezana Popovic-Pejicic
Prilozi (Makedonska Akademija Na Naukite I Umetnostite. Oddelenie Za Medicinski Nauki)|July 15, 2023
The Role of Protein Restriction in the Progression of Chronic Kidney DiseaseNereida Spahia, Merita Rroji, Myftar Barbullushi, et al.
Metabolic Syndrome and Related Disorders|July 11, 2023
Subclinical Hypothyroidism, Kidney, and Heart from Normal to Uremic MilieuNereida Spahia, Merita Rroji, Myftar Barbullushi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 18, 2017
Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis PatientsMerita Rroji, Nereida Spahia, Saimir Seferi, et al.
International Urology and Nephrology|January 10, 2024
Sodium and water dynamics in the progression of chronic kidney disease: mechanisms and clinical significanceNereida Spahia, Merita Rroji, Alma Idrizi, et al.
Metabolic Syndrome and Related Disorders|February 22, 2024
A New Hope on the Horizon for Kidney and Cardiovascular Protection with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists in Type 2 Diabetic and Chronic Kidney Disease PatientsGoce Spasovski, Merita Rroji, Goce Hristov, et al.
International Urology and Nephrology|April 18, 2013
Is residual renal function and better phosphate control in peritoneal dialysis an answer for the lower prevalence of valve calcification compared to hemodialysis patients?Merita Rroji, Saimir Seferi, Majlinda Cafka, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2025
Cognitive impairment in kidney transplanted patientsJolanta Malyszko, Aleksandra Golenia, Michele Farisco, et al.
Prilozi (Makedonska Akademija Na Naukite I Umetnostite. Oddelenie Za Medicinski Nauki)|February 26, 2015
Editorial policies and background in editing Macedonian Medical Review and BANTAO journalGoce Spasovski
Pageof 17